Delivery Order 36C24822D0086-36C24825N0952

Award Date 8/1/25
Potential Completion Date 7/31/26
Potential Value $120K
Ultimate Awardee
Not listed
Federal Contract Vehicle
Set-Aside Type
No Set-Aside Used
Extent Competed
Not Competed
Major Defense Program
Not listed
Pricing Type
Firm Fixed Price
Place of Performance
Redwood City, CA 94065, USA
Solicitation Procedures
Only One Source
Number Of Offers Received
Not listed
Legislative Mandate
Not listed
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
Similar Awards
The U.S. Department of Veterans Affairs (VA) Veterans Integrated Service Network 8 has awarded Karius, Inc. a firm-fixed-price delivery order contract for its Karius Next Generation Sequencing (NGS) diagnostic test. The contract has a ceiling value of $60,000 and a performance period from August 1, 2023 to July 31, 2024. This award is part of a larger $600,000 Indefinite Delivery Contract (IDC) that Karius holds with the VA VHA, which has an ultimate completion date of July 31, 2027. The...
This is a Delivery Order contract awarded to Karius, Inc. by the Department of Veterans Affairs Veterans Health Administration (VA VHA), with a ceiling value of $55,000.00. The contract is for Karius' provision of specialized molecular diagnostic testing and next-generation sequencing (NGS) services, including quantitative genomic testing to rapidly identify pathogens and monitor antimicrobial resistance. The contract has no set-aside designation, indicating Karius is competing as a standard...
This is a firm fixed-price delivery order awarded by the Department of Veterans Affairs Veterans Health Administration (VA VHA) to Karius, Inc. for the provision of next-generation sequencing (NGS) tests. The contract, valued at $120,000.00, has an ultimate completion date of July 31, 2025. Karius, Inc. is the sole source provider of these specialized NGS tests for the VA VHA, as the agency determined the company to be the only responsible source capable of meeting its requirements. This...
This contract was awarded by the National Institutes of Health (NIH) Clinical Center to Karius, Inc., a life sciences company specializing in diagnostic testing for infectious diseases. The contract, valued at $80,000.00, is for the provision of molecular diagnostic testing services using Karius' liquid biopsy technology to rapidly screen patients for various pathogens. The testing services will be delivered within 3-4 days of specimen receipt. This is a firm fixed-price purchase order...
This federal contract award is to Karius, Inc., a life sciences company specializing in diagnostic science and technology for infectious diseases. The $240,000.00 Purchase Order contract is for the provision of a Quantitative Next-Gen Sequencing Test to the Defense Health Agency, a defense agency. The contract has a period of performance through September 30, 2027 and was awarded on a Firm Fixed Price basis without any set-aside designation. Karius, Inc. has secured multiple prior federal...
This is a firm fixed price purchase order awarded by the Defense Health Agency (DHA) to Karius, Inc. for quantitative next-generation sequencing testing services. The $240,000 contract supports DHA programs through September 2023 and leverages Karius' expertise in genomic sequencing to rapidly screen patients for various pathogens. This is a sole source award, as Karius is the only commercial laboratory capable of providing the requested cell-free DNA testing from plasma samples with 24-72...
The Department of the Navy Bureau of Medicine and Surgery awarded a $140,000 firm fixed price purchase order to Karius, Inc. for the provision of 70 quantitative next generation sequencing tests. This award is not associated with a larger contract vehicle and does not have a set-aside designation. Karius, Inc. is a life sciences company focused on diagnostic testing for infectious diseases. The purchase order supports Department of Defense programs through September 2027 and leverages Karius'...
This is a $630,976 firm fixed-price definitive contract awarded by the Office of the Assistant Secretary for Preparedness and Response (ASPR), a civilian federal agency, to Karius, Inc., a life sciences company headquartered in Redwood City, California. The contract is for research and development of metagenomic sequencing of microbial cell-free DNA and RNA for comprehensive pathogen detection. Karius, Inc. is a specialized provider of advanced molecular diagnostic testing and next-generation...
The Defense Health Agency (DOD) awarded a $250,000 firm fixed price purchase order to Karius, Inc., doing business as Karius Inc., located in San Diego, California. The contract is for Quantitative Next-Gen Sequencing Testing Services and has a period of performance from October 1, 2022 through September 30, 2023. Karius provides genomic sequencing and bioinformatics analysis services to identify pathogens and monitor antimicrobial resistance. No applicable subcontractors were identified in...
The Department of Veterans Affairs Veterans Health Administration Veterans Integrated Service Network 8 awarded a $22,000 firm fixed price delivery order contract to Karius, Inc., doing business as Karius, to provide Karius Laboratory Tests for the Orlando VA Medical Center. Karius will perform laboratory testing services for the Orlando VAMC from its location in Redwood City, California under the one-year contract running from August 2022 through July 2023. The Veterans Health Administration...
  • 36C24822D0086
    Indefinite Delivery Contract
  • 36C24822D0086-36C24825N0952
    Delivery Order

This is a federal contract award to Karius, Inc., a life sciences company specializing in next-generation sequencing (NGS) and molecular diagnostic testing services. The contract, awarded by the U.S. Department of Veterans Affairs (VA), is an Indefinite Delivery Contract (IDC) valued at up to $120,000,000. Under this IDC, the VA can purchase Karius' KARIUS NEXT GENERATION SEQUENCING TEST at $2,000 per test, with Karius identified as the sole responsible source. The contract has a period of performance through July 31, 2026. This contract does not have a set-aside designation, indicating Karius competed as a standard for-profit organization. The contract will enable the VA to leverage Karius' advanced diagnostic technologies to support comprehensive healthcare services for veterans nationwide.

Generated 8/3/25, 1:17 AM